Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Clinical trial NCT02790515 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02790515
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma Chronic Myeloid Leukemia (CML)Juvenile Myelomonocytic Leukemia (JMML)Myelodysplastic Syndrome (MDS)Non-Hodgkin Lymphoma (NHL)

Start date: 2016-07-14
Primary completion: 2025-07-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.